Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines ophthalmology and pharmacology to enable optimal treatment, prevention, and diagnosis of ocular diseases and disorders. It presents the latest in the ophthalmic drug discovery, delivery, and product development, emphasizing biopharmaceutics, pharmacokinetics, pharmacodynamics, and mechanisms of drug action.

Journal of Ocular Pharmacology and Therapeutics coverage includes:

Drug discovery and development
Mechanisms of drug action
Drug delivery, nanomedicine, and nanotechnology
Biopharmaceutics, pharmacokinetics, pharmacodynamics, and mathematical modeling
Drug transporters and drug metabolism
Pre-clinical and early-stage clinical trial results
Gene and cell-based therapies
Combination products
Ocular pharmacotherapy/clinical trials/biomarkers
Ocular toxicology and toxicokinetics
Dry eye and ocular surface diseases
Corneal diseases
Glaucoma and optic neuropathies
Retinal diseases
Lens and cataract
Ocular infection and trauma
Ocular inflammatory and immune disorders
Ocular ischemia and blood flow
Ocular metabolic disorders
Ocular pain
Oculomotor complications
Proliferative disorders of the eye
Therapeutics for myopia and refractive errors
Therapeutics for strabismus, ambylopia, and visual processing
Eyes on New Product Development — written by Gary D. Novack, PhD, featuring the latest updates on drug and device pipeline developments as well as policy/regulatory changes by the FDA

Editor-in-Chief
W. Daniel Stamer, PhD
Duke University
Durham, NC   
Associate Editors
Drug Delivery
Uday B. Kompella, PhD
University of Colorado Denver
Denver, CO  

Retinal Pharmacology
Michael R. Niesman, PhD
MingSight Pharmaceuticals 
San Diego, CA
Pre-clinical Ocular Pharmacology
Naj A. Sharif, PhD, FARVO
Santen Incorporated
Emeryville, CA 
Ocular Surface Pharmacology
Linda D. Hazlett, PhD
Wayne State University School of Medicine
Detroit, MI

Aqueous Humor Dynamics
Carol B. Toris, PhD 
Case Western Reserve University
Cleveland, OH
Editorial Board
Natalie Afshari, MD, FACS
University of California, San Diego
La Jolla, CA
Makoto Aihara MD, PhD
University of Tokyo
Tokyo, Japan

Michael Allingham, MD, PhD
Duke University
Durham, NC
Curtis R. Brandt, PhD
University of Wisconsin-Madison
Madison, WI
Alain M. Bron, MD 
University Hospital
Dijon, France
  
Abbot Clark, PhD
The University of North Texas Health Science Center 
Fort Worth, TX
  
Craig E. Crosson, PhD
Medical University of South Carolina
Charleston, SC
Emmett Thomas Cunningham Jr, MD, PhD, MPH
Stanford University School of Medicine
Stanford, CA
Cintia De Paiva, MD, PhD
Baylor College of Medicine
Houston, TX
Nicholas A. Delamere, PhD
University of Arizona
Tucson, AZ

Filippo Drago, MD, PhD
University of Catania Medical School
Catania, Italy
Juana Gallar, MD, PhD
Instituto de Neurociencias UMH-CSIC
San Juan de Alicante, Spain
Deniz Hos, MD, PhD
University of Cologne
Cologne, Germany

Ashwath Jayagopal, MBA, PhD
F. Hoffmann-La Roche Ltd
Basel, Switzerland

Jost B. Jonas, MD
Mannheim of the Ruprecht-Karls-University Heidelberg
Mannheim, Germany
Achim H. Krauss, PhD
AxeroVision, Inc.
Carlsbad, CA
Hyung Keun Lee, MD
Yonsei University College of Medicine
Seoul, Korea
Goldis Malek, PhD
Duke University
Durham, NC
Alan D. Marmorstein, PhD
Mayo Clinic
Rochester, MN   
Rajiv R. Mohan, MSc, PhD, FARVO 
University of Missouri
Columbia, MO
Gary D. Novack, PhD
Pharma-Logic Development, Inc.
San Rafael, CA 
Ganesh Prasanna, PhD
Novartis Institutes for Biomedical Research (NIBR)
Cambridge, MA
Settimio Rossi, MD 
University of Campania Medical School
Naples, Italy

Daniel Saban, PhD
Duke University
Durham, NC  
Leopold Schmetterer, PhD
Singapore Eye Research Institute
Singapore, Singapore 
Angela M. Suburo, MD, PhD
Universidad Austral, Pilar
Buenos Aires, Argentina

Chi-Ho To, PhD
The Hong Kong Polytechnic University
Kowloon, Hong Kong
Jia Yin, MD, PhD 
Harvard Medical School
  Massachusetts Eye and Ear Infirmary 
Boston, MA
Thomas Yorio, PhD
The University of North Texas Health Science Center 
Fort  Worth, TX
Husam S. Younis, PharmD, PhD
NGM Biopharmaceuticals, Inc.
South San Francisco, CA 
Oliver Zeitz, MD
Charité Universitätsmedizin
Berlin, Germany
Founding Editor
George C.Y. Chiou, PhD
Editorial Coordinator
Laura Neuberger
optjournal@verizon.net